Package Description

Early on during the pandemic, the Food and Drug Administration issued guidance to help expedite the development of COVID-19 vaccines. This session will provide an overview of expedited vaccine development, explain the potential importance of vaccine booster doses, and discuss the COVID-19 vaccines available for various populations.

Learning Objectives:

After completing this course, learners should be able to:

• provide an overview of expedited vaccine development
• explain the potential importance of vaccine booster doses
• discuss the COVID-19 vaccines available for various populations

Price:

• Members: $15
• Non-members: $30

CE Information:

CE Credits: 1.00

Click here to view detailed CE information about this course.

Speakers:

Peter Marks, MD, PhD

Dr. Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women's Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

Disclosures: No relevant financial relationships to disclose